These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 28765194
41. Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: a double-blind placebo-controlled study. Sakata R, Nakamura T, Torimura T, Ueno T, Sata M. Int J Mol Med; 2013 Nov; 32(5):989-94. PubMed ID: 24065295 [Abstract] [Full Text] [Related]
42. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Hsu CH, Liao YL, Lin SC, Tsai TH, Huang CJ, Chou P. Altern Med Rev; 2011 Jun; 16(2):157-63. PubMed ID: 21649457 [Abstract] [Full Text] [Related]
43. Plant polyphenols attenuate hepatic injury after hemorrhage/resuscitation by inhibition of apoptosis, oxidative stress, and inflammation via NF-kappaB in rats. Relja B, Töttel E, Breig L, Henrich D, Schneider H, Marzi I, Lehnert M. Eur J Nutr; 2012 Apr; 51(3):311-21. PubMed ID: 21698494 [Abstract] [Full Text] [Related]
44. Green tea catechins prevent low-density lipoprotein oxidation via their accumulation in low-density lipoprotein particles in humans. Suzuki-Sugihara N, Kishimoto Y, Saita E, Taguchi C, Kobayashi M, Ichitani M, Ukawa Y, Sagesaka YM, Suzuki E, Kondo K. Nutr Res; 2016 Jan; 36(1):16-23. PubMed ID: 26773777 [Abstract] [Full Text] [Related]
45. Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Hsu CH, Tsai TH, Kao YH, Hwang KC, Tseng TY, Chou P. Clin Nutr; 2008 Jun; 27(3):363-70. PubMed ID: 18468736 [Abstract] [Full Text] [Related]
46. Effects of green tea extract on overweight and obese women with high levels of low density-lipoprotein-cholesterol (LDL-C): a randomised, double-blind, and cross-over placebo-controlled clinical trial. Huang LH, Liu CY, Wang LY, Huang CJ, Hsu CH. BMC Complement Altern Med; 2018 Nov 06; 18(1):294. PubMed ID: 30400924 [Abstract] [Full Text] [Related]
47. Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience. Marcinak JF, Munsaka MS, Watkins PB, Ohira T, Smith N. Drug Saf; 2018 Jun 06; 41(6):625-640. PubMed ID: 29492878 [Abstract] [Full Text] [Related]
52. Hypoglycemic effect of soluble polysaccharide and catechins from green tea on inhibiting intestinal transport of glucose. Lee YE, Yoo SH, Chung JO, Park MY, Hong YD, Park SH, Park TS, Shim SM. J Sci Food Agric; 2020 Aug 06; 100(10):3979-3986. PubMed ID: 32342987 [Abstract] [Full Text] [Related]
53. Catechins in dietary supplements and hepatotoxicity. Navarro VJ, Bonkovsky HL, Hwang SI, Vega M, Barnhart H, Serrano J. Dig Dis Sci; 2013 Sep 06; 58(9):2682-90. PubMed ID: 23625293 [Abstract] [Full Text] [Related]
55. Effect of chronic consumption of Piliostigma thonningii on activities of alanine aminotransferase and aspartate aminotransferase in serum and liver in Rattus novergicus. Awhin EP, Jeroh E, Anigboro AA, Rachael N. Pak J Biol Sci; 2013 Dec 15; 16(24):2062-5. PubMed ID: 24517031 [Abstract] [Full Text] [Related]
60. Comparative safety evaluation of Chinese Pu-erh green tea extract and Pu-erh black tea extract in Wistar rats. Wang D, Xiao R, Hu X, Xu K, Hou Y, Zhong Y, Meng J, Fan B, Liu L. J Agric Food Chem; 2010 Jan 27; 58(2):1350-8. PubMed ID: 20028013 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]